Healthcare Providers
Innovative Non-Invasive Neuromodulation System
PoNS is indicated as a prescription-only therapy for adults 22+ as an adjunct to a supervised therapeutic exercise program, for the treatment of gait deficitsdue to mild-to-moderate multiple sclerosis or chronic stroke symptoms. It includes:
-
- Controller
The unit you program in the PoNS Software.It stores the patient’s regimen, delivers thestimulation, and records every session:duration, intensity, and tongue contact. - Mouthpiece
The tongue-contact piece the patient inserts each session. It connects to the Controllerand delivers the stimulation set on the device.
- Controller
The Science Behind PoNS1,2
Translingual Neurostimulation (TLNS):
When the PoNS device is on, the electrodes on the mouthpiece send mild electrical impulses to the cranial nerves on the surface of the tongue. This electrical stimulation creates a flow of neural impulses into the brainstem and cerebellum— the body’s movement control center.
Brain & Neuroplasticity:
From the brainstem, these impulses travel throughout the brain and activate a neural network involved in regulating motor function and initiate a cascade of changes in multiple brain regions resulting, with consistent use, in neuroplasticity.
How PoNS is Applied
PoNS is to be used in conjunction with supervisedtherapeutic exercise, referred to as PoNS Therapy.
PoNS Therapy is a comprehensive 12-week program for patients with chronic stroke symptoms or 14-week program for patients with MS which combines in-clinic and in-home use of the PoNS device guided bya PoNS clinician to focus on targeted therapeutic exercises.
The Benefit of PoNS
Real World Evidence
In all clinical studies and the real-world utilization, no one experienced any serious or persistent side effects associated with the device.
Have a patient in mind who can benefit from PoNS Therapy:
Use the Bioness prescription form here or if using your own Prescription Form, please ensure the following information is included:
- Patient name, address, and phone number
- Prescriber name, NPI number, and license number
- Prescription signed and dated by the prescriber
- Device Prescribed: PoNS Controller and PoNS Mouthpiece
- Quantity Prescribed
Interested in becoming a PoNS Therapist?
Create a flexible rehabilitation plan that allowsyour patients to build endurance using gait training, balance training and breathing and awareness training (BAT) with PoNS Therapy to see theneuroplastic gains.
- Complete PoNS Training Module
- Activate PoNS software
- Begin PoNS Therapy with Patient
Contact us to learn more about PoNS.
- Ptito et al. (2019); Presented at 9th Annual Traumatic Brain Injury Conference (Arlington, VA)
- Danilov et al. (2015); in Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects (CRC Press)
- Helius Medical Inc. (2020); Real World Evidence Study (Data on file, August 2, 2020)
- Helius Medical Inc. (2023); Statistical Analysis Report (Data on file, January 26, 2023)
Indications for Use: The PoNS device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only. The PoNS device is indicated for use as a treatment of dynamic gait deficits due to chronic symptoms from stroke and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.
The PoNS device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for wearable electrical stimulation medical devices. Electrical stimulation should not be used: if there is an active or suspected malignant tumor, in areas of recent bleeding or open wounds, and in areas that lack normal sensation. The PoNS has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS if you are sensitive to nickel, gold or copper.
Full prescribing information can be found in product labeling or at: www.bionessmedical.com/pons/safety-information.
Instructions for Use / Patient Guides can be made available upon request.
Contact [email protected] or 855-902-5252 to request an electronic copy.
